Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anatolian Journal of Cardiology|August 3, 2017
High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterolKaterina Tosheska Trajkovska, Sonja Topuzovska
Frontiers in Genetics|September 19, 2022
Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis developmentMarija Vavlukis, Ana Vavlukis, Katerina Krsteva, et al.
Open Access Macedonian Journal of Medical Sciences|September 22, 2017
The Influence of Anterior Cruciate Ligament Remnant on Postoperative Clinical Results in Patients with Remnant Preserving Anterior Cruciate Ligament ReconstructionAlan Andonovski, Sonja Topuzovska, Milan Samardziski, et al.
Prague Medical Report|October 7, 2019
Lipoprotein(a) - Link between Atherogenesis and ThrombosisDanica Labudovic, Irena Kostovska, Katerina Tosheska Trajkovska, et al.
Journal of Medical Biochemistry|June 19, 2020
Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuriaIrena Kostovska, Katerina Tosheska-Trajkovska, Sonja Topuzovska, et al.
Advances in Clinical Chemistry|June 6, 2022
Nephrinuria and podocytopathiesIrena Kostovska, Katerina Tosheska Trajkovska, Sonja Topuzovska, et al.
Turkish Journal of Urology|November 23, 2022
AHNAK2 Urinary Protein Expression as Potential Biomarker for Bladder Cancer Detection: A Pilot StudySelim Komina, Gordana Petrusevska, Rubens Jovanovic, et al.
Urology Annals|August 23, 2021
Effect of bladder cancer variant histology on survival outcome in patients treated with radical cystectomy: A single-centre experienceSelim Komina, Gordana Petrusevska, Vesna Janevska, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|August 12, 2020
Role of urinary podocalyxin in early diagnosis of diabetic nephropathyIrena Kostovska, Katerina Tosheska Trajkovska, Svetlana Cekovska, et al.
Journal of Medical Biochemistry|November 24, 2025
Role of lipoprotein-associated phospholipase A2 (LP-PLA2) in the prediction and assessment of the severity of coronary artery disease in patients with type 2 diabetes mellitusIrena Kostovska, Svetlana Cekovska, Katerina Tosheska'Trajkovska, et al.
Pageof 1